The purpose of this study is to investigate the efficacy of umbilical cord mesenchymal stem
cells (MSCs) transfusion in the treatment of liver cirrhosis. Liver function will be
monitored by serum analysis. The levels of serum alanine aminotransferase (ALT), total
bilirubin (TB), prothrombin time (PT), prealbumin(PA) and albumin (ALB) will be examined at
pre-transfusion, and 3 days to 2 years post-transfusion. Child-Pugh scores, Model for
End-Stage Liver Disease scores and clinical symptoms will be assessed simultaneously.